Search Results - "Muigai, R. K."

Phase 2 Efficacy Trial of an Oral 8-Aminoquinoline (WR6026) for Treatment of Visceral Leishmaniasis by Sherwood, J. A., Gachihi, G. S., Muigai, R. K., Skillman, D. R., Mugo, M., Rashid, J. R., Wasunna, K. M. A., Were, J. B. O., Kasili, S. K., Mbugua, J. M., Kirigi, G., Schaefer, K. U., Oster, C. N., Fleckenstein, L. L., Berman, J. D., Brewer, T. G., Roberts, C. R., Johnson, A. J., Schuster, B. G.

“…The efficacy of an oral 8-aminoquinoline (8-[[6-(diethylamino)hexyl]amino]-6-methoxy-4-methylquinoline) (WR6026) in the treatment of 16 patients with kala azar…”
Get full text

Relationship between direct agglutination test and splenic aspirate smear parasite load in visceral leishmaniasis at Baringo District, Kenya by Nyakundi, P M, Gachihi, G S, Muigai, R K, Were, J B, Wasunna, K M, Rashid, R J, Ogola, J J, Kirigi, G, Mbugua, J

“…Direct agglutination test was carried out in Baringo District on 100 persons presenting with signs and symptoms suggestive of visceral leishmaniasis. Splenic…”
Get more information

Schistosomiasis caused by Schistosoma mansoni in Baringo District, Kenya: case report by Muigai, R K, Wasunna, K, Gachihi, G, Kirigi, G, Mbugua, J, Were, J B

“…Schistosomiasis caused by Schistosoma mansoni has not been reported in Baringo District of Rift Valley Province. The intermediate host (Biomphalaria species)…”
Get more information